US Stock MarketDetailed Quotes

NVO Novo-Nordisk A/S

Watchlist
  • 89.550
  • -1.400-1.54%
Close Feb 26 16:00 ET
  • 89.390
  • -0.160-0.18%
Pre 06:02 ET
397.66BMarket Cap28.15P/E (TTM)

About Novo-Nordisk A/S Company

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsv?rd, Denmark.

Company Profile

SymbolNVO
Company NameNovo-Nordisk A/S
Listing DateJul 9, 1981
Founded1931
CEOMr. Lars Fruergaard Jorgensen
MarketNYSE
Employees77349
Securities TypeDR
ADS Ratio1.0 : 1.0
Fiscal Year Ends12-31
AddressNovo Allé 1
CityBagsv?rd
ProvinceCapital Region
CountryDenmark
Zip Code2880
Phone45-44-44-88-88

Company Executives

  • Name
  • Position
  • Salary
  • Lars Fruergaard Jorgensen
  • Chief Executive Officer and President
  • --
  • Karsten Munk Knudsen
  • Executive Vice President and Chief Financial Officer
  • 26.80M
  • Marcus Schindler, PhD
  • Executive Vice President, Research and Early Development and Chief Scientific Officer
  • --
  • Ludovic Helfgott
  • Executive Vice President, Rare Disease
  • --
  • Henrik Ehlers Wulff
  • Executive Vice President, Product Supply, Quality Assurance, Digital Data and Information Technology
  • --
  • Maziar Mike Doustdar
  • Executive Vice President, International Operations
  • --
  • Martin Holst Lange
  • Executive Vice President, Development
  • --
  • Camilla Sylvest
  • Executive Vice President, Commercial Strategy and Corporate Affairs
  • --
  • Helge Lund
  • Chairman of the Board
  • 4.30M
  • Henrik Poulsen
  • Vice Chairman of the Board
  • 2.60M
  • Thomas Rantzau
  • Director
  • 1.00M
  • Liselotte Hyveled
  • Director
  • 1.20M
  • Elisabeth Dahl Christensen
  • Director
  • 1.10M
  • Kasim Kutay
  • Director
  • 1.50M
  • Mette Bojer Jensen
  • Director
  • 1.30M
  • Dr. Sylvie Gregoire,Pharm.D.
  • Independent Director
  • 2.30M
  • Christina Law
  • Independent Director
  • 1.25M
  • Andreas Fibig
  • Independent Director
  • 1.70M
  • Laurence Debroux
  • Independent Director
  • 2.10M
  • Dr. Martin W. Mackay, PhD
  • Independent Director
  • 1.65M
  • David Moore
  • Executive Vice President, US Operations and Business Development
  • --
  • Tania Sabroe
  • Executive Vice President, People and Organisation
  • --
Trending Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.